Illumina - M&A Summary and Business Overview

Life ScienceCompany

Illumina M&A Summary

Illumina has acquired 29 companies, including 16 in the last 5 years. It has also divested 4 assets.

Illumina’s largest acquisition to date was in 2020, when it acquired GRAIL for $8.0B. It’s largest disclosed sale occurred in 2023, when it sold Verogen to Qiagen N.V for $150M. Illumina has acquired in 9 different US states, and 9 countries. The Company’s most targeted sectors include life science (63%) and medical products (11%).

Illumina Business Overview

Where is Illumina headquartered?

Illumina is headquartered in San Diego, California.

What is Illumina’s revenue?

Illumina disclosed revenue of 4,504M USD for 2023 and 4,584M USD for 2022.

How many employees does Illumina have?

Illumina has 10,590 employees.

What sector is Illumina in?

Illumina is a life science company.

When was Illumina founded?

Illumina was founded in 1998.

M&A Summary

  • M&A Total Activity32
    • M&A Buy Activity29
    • M&A Sell Activity3
  • Total Sectors Invested 8
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 6
  • M&A Advisors 4

Illumina

Illumina, Inc.

5200 Illumina Way,
San Diego, California 92122
United States,
(858) 202-4500
www.illumina.com

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. The Company's customers include genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. Illumina was formed in 1998 and is based in San Diego, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (3.2/yr) # 13 2 - 13 - 1 29
vol $555M $8.0B $8.6B
Sell (0.4/yr) # 1 - - 1 1 - 3
vol $150M $150M
  32

Most Recent M&A

Company Date Value Type
Fluent BioSciences, Inc. 2024-07-09 - Add-on Acquisition
Watertown, Massachusetts · www.fluentbio.com
Verogen, Inc. 2023-01-09 150M USD Trade Sale
San Diego, California · www.verogen.com
Dama Health Ltd. 2022-09-14 - Stake Purchase
London, United Kingdom · www.damahealth.com
Pandora Biosciences, Inc. 2022-09-14 - Stake Purchase
, South Africa · www.pandorabiosciences.com
Viridian Seeds, Inc. 2022-09-14 - Stake Purchase
Cork, Ireland · www.viridianseeds.com
Terrapeutics Pharma Ltd. 2022-09-14 - Stake Purchase
Jerusalem, Israel · www.terrapeuticspharma.com
Nusantics Ltd. 2022-09-14 - Stake Purchase
Jakarta, Indonesia · www.nusantics.com
Acrobat Genomics, Inc. 2022-09-14 - Stake Purchase
Stanford, California · www.acrobatgenomics.com
Rethink Bio Pvt. Ltd. 2022-03-16 - Stake Purchase
Pune, India · www.rethinkbio.in
Purpose Health, Inc. 2022-03-16 - Stake Purchase
McLean, Virginia · www.purposedbio.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 18 (62%) 8.0B (94%) - -
Medical Products 3 (10%) 105M (1%) 1 (33%) 150M (100%)
Information Technology 2 (7%) 450M (5%) 1 (33%) -
Healthcare Services 2 (7%) - - -
Software 1 (3%) - 1 (33%) -
Information Services 1 (3%) - - -
Internet Software and Services 1 (3%) - - -
Test/Measurement Equipment 1 (3%) - - -
Total 29 $8.6B 3 $150M

By Geo

State/Country Buy Value Sell Value
United States 20 8.6B 3 150M
  California 11 8.1B 2 150M
  Massachusetts 2 - - -
  Utah 1 450M 1 -
  Wisconsin 1 - - -
  Virginia 1 - - -
  North Carolina 1 - - -
  Illinois 1 - - -
  Georgia 1 - - -
  British Columbia 1 - - -
United Kingdom 2 - - -
Australia 1 - - -
India 1 - - -
Indonesia 1 - - -
Ireland 1 - - -
Israel 1 - - -
Netherlands 1 - - -
South Africa 1 - - -
Domestic 20 (69%) 8.6B (100%) 3 (100%) 150M (100%)
Cross-border 9 (31%) - - -
Total 29 $8.6B 3 $150M

Top M&A Advisors

Financial Deals
BofA Securities
1
Goldman Sachs
1
Legal Deals
Covington & Burling
1
Cravath, Swaine & Moore
1

Deal Values

buy # Total
> $1B 1 $8.0B
$100M to $1B 2 $555M
TOTAL $8.6B
Largest GRAIL, Inc.
$8.0B (2020-09-21)
sell # Total
$100M to $1B 1 $150M
TOTAL $150M
Largest Verogen, Inc.
$150M (2023-01-09)

M&A Connections

Deals
Divested to
Strategic(s)
100%
3 (100%)

 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.